Extra Corporeal Membrane Oxygenation (ECMO) System Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Modality, Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR)) and Geography.

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.71 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The growth of the extracorporeal membrane oxygenation (ECMO) system market can be contributed to the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences & training programs to increase awareness, and technological advancements. In addition, the rising geriatric population and the number of people suffering from diseases in populous countries such as India & China are factors that are expected to offer significant growth opportunities for ECMO systems.

However, complications associated with extracorporeal membrane oxygenation machine such as bleeding, infections, and technical failures; along with high cost and lack of skilled professionals is a challenge to the market.

Scope of the Report

Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of gas exchange or perfusion to sustain life. The technology for ECMO is largely derived from cardiopulmonary bypass, which provides shorter-term support with arrested native circulation.

In the report, a detailed analysis of the Infectious disease diagnostics market is provided. The market is evaluated by Modality, Application, Geography.

By Modality
Veno-Arterial (VA)
Veno-Venous (VV)
By Application
Respiratory Applications
Cardiac Applications
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Respiratory Applications is expected to Dominate the Market

Asthma is one of the major noncommunicable diseases. It is a chronic disease of the air passages of the lungs which inflames and narrows them. According to a World Health Organization 2017 report, there are approximately 235 million people suffering from asthma globally. As per this report, there were 383,000 deaths due to asthma in 2015. Moreover, the prevalence of asthma seems to be increasing at a rapid pace.

As per the Center for Disease Control and Prevention (CDC) 2016 report, the prevalence of asthma among adults aged 20 and over increased from 7.1% in 2009-2010 to 9.2% in 2013-2014. Therefore ECMO is useful as to provide adequate gas exchange and prevent lung injury induced by mechanical ventilation. This is very helpful for asthama patients.

As a result, the use of ECMO in cases of near-fatal asthma (NFA) has increased over the years, as per a report by Hye Ju Yeo et al., published in Critical care Journal 2017. Hence all these factors are expected to help the market growth.


North America is Expected to Dominate the Market

As per the American heart association, coronary heart disease is the leading cause of deaths (45.1%) attributable to the cardiovascular disease in the United States, followed by stroke (16.5 %) and heart failure (8.5 %). Moreover, about 5.7 million adults in the United States die of heart failure every year, of which the percentage of in-hospital failures holds a huge potential to be reduced by the usage of ECMO. COPD is the third-leading cause of death in the United States, with its prevalence increasing in direct correlation with changing demography. Although, non-invasive mechanical ventilation (NIV) is the primary prognosis, a shift has been observed, in recent years, toward ECMO (which is considered to be a more efficient alternative). 

According to a recent article published in 2018, the use of extracorporeal membrane oxygenation (ECMO) has been exponentially increasing over the last decade and is now considered as a mainstream lifesaving treatment modality in critical care medicine. 

Hence, the survival rates for adults with severe acute respiratory failure treated with ECMO have also improved dramatically over the past 30 years. These factors are expected to help the market grow in the region.


Competitive Landscape

Majority of the extra corporeal membrane oxygenation system are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases

      2. 4.2.2 Technological Advancements in ECMO Technology

      3. 4.2.3 Increased Adoption of ECMO Systems

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of ECMO Procedures

      2. 4.3.2 Risks Associated with ECMO System

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Modality

      1. 5.1.1 Veno-Arterial (VA)

      2. 5.1.2 Veno-Venous (VV)

      3. 5.1.3 Others

    2. 5.2 By Application

      1. 5.2.1 Respiratory Applications

      2. 5.2.2 Cardiac Applications

      3. 5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Alung Technologies Inc.

      2. 6.1.2 Eurosets

      3. 6.1.3 Getinge AB

      4. 6.1.4 Livanova Plc

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 Microport Scientific Corporation

      7. 6.1.7 Nipro Medical Corporation

      8. 6.1.8 Terumo Medical Corporation

      9. 6.1.9 Abbott Laboratories

      10. 6.1.10 Xenios AG (FRESENIUS SE & CO. KGAA)​​

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Extra Corporeal Membrane Oxygenation (ECMO) System Market market is studied from 2018 - 2026.

The Extra Corporeal Membrane Oxygenation (ECMO) System Market is growing at a CAGR of 4.71% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Getinge AB, Livanova Plc, Medtronic, Terumo Medical Corporation, Eurosets are the major companies operating in Extra Corporeal Membrane Oxygenation (ECMO) System Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!